News & Updates

Treatment with the oral form of nalbuphine, PHN131, appears to effectively control moderate-to-severe pain in patients who have undergone hemorrhoidectomy, according to a study.

In the treatment of Crohn’s disease (CD), the triple combination of vedolizumab, adalimumab, and methotrexate leads to endoscopic remission in 34.5 percent of patients and clinical remission in 54.5 percent, according to data from the phase IV EXPLORER trial.

Normal-tension glaucoma (NTG) patients with hypertension who experience morning blood pressure (BP) surge are likely to have visual field progression, as shown in a study.

Tacrolimus given once daily significantly reduced the 3-year incidence of chronic lung allograft dysfunction (CLAD) in lung transplant patients compared with standard immunosuppressant in the open label, multicentre, ScanCLAD trial presented at ERS 2023.

Mefenamic acid shows no significant interaction with ciprofol in healthy individuals, which suggests that ciprofol is safe and well tolerated when administered along with mefenamic acid, reports a study.

The risk of herpes zoster (HZ) and HZ-related hospitalization is much higher among patients with liver cirrhosis (LC), especially those who are not currently recommended for HZ vaccination, than the general population, according to a nationwide population-based study in Korea.